Dhanuka Agritech Q2 FY27 Earnings Call — Analysis (NSE: DHANUKA)

Dhanuka Agritech delivered 9.9% YoY revenue growth and 16.2% PAT growth in Q2FY27 driven by insecticides and lean channel inventory, but guided for low single-digit growth and ~100 bps gross margin contraction for the full year amidst El Niño headwinds.

4 Nov 2026 · Analysis by Alpha Inflection

Result quality: stable — Results context unavailable. Management sentiment: optimistic.

The take

Q2FY27 Bayer Royalty Income ₹6.5 Cr ( +51.16% YoY ) . Guidance raised — FY27 fy27 consolidated margin contra… ~100 bps gross margin contraction; similar/slightly more EBITDA margin contraction . New story: Bio-stimulants regulatory tailwind .

Results

Revenue ₹657.51 Cr (+9.91% YoY); EBITDA ₹152.97 Cr (+11.88% YoY); PAT ₹109.22 Cr (+16.23% YoY).

Financial highlights

Guidance

Full-year revenue growth guided to low single-digits with ~100 bps gross margin contraction and a similar decline in EBITDA margin.

What management committed to

• [Dhanuka Agritech] will launch [Dhanzyme Gold] in liquid formulation in December [2026]. — 1 product launch (Dhanzyme Gold liquid), Q3FY27
• [The Dahej plant] will have 4 products in its portfolio in FY28, up from 2, including capacity expansion of existing products and the addition of 2 new fungicide products. — 4 products (from 2), including 2 new fungicides, FY28
• [Dhanuka Agritech's] FY27 full-year consolidated gross margin will contract by approximately 100 bps, and EBITDA margin will contract by a similar or slightly more amount. — ~100 bps gross margin contraction; similar/slightly more EBITDA margin contraction, FY27

Key themes

Insecticide outperformance amidst El Niño challenges

How the narrative shifted

• Monsoon deficit disrupts kharif demand: Reinforced as the primary macro headwind explaining Q2 performance and subdued H2 outlook, with specific mention of regional crop impact.
• Nagpur automated formulation capacity: Absent from the current quarter's narrative, possibly reflecting its long-dated timeline (April 2028) and more immediate operational focus on Dahej and product mix.
• Bio-stimulants regulatory tailwind: Transitions from a regulatory hope narrative to a tangible revenue contributor story, with specific products launched and credited for margin defense.
• International Bayer product buildout: Downplays commercial activity (subsidiaries for registration only) but reports tangible progress in customer appointments (14 countries) and purchase orders (5).
• Dahej plant underperformance persists: Remains a loss-making entity but shows improvement (50% less EBITDA loss vs prior H1). Narrative extends beyond breakeven to capacity expansion and new product addition for FY28, shifting from pure defense to a managed turnaround story.
• Portfolio mix shifting to low-dose products: Explicitly credited with protecting gross margins in Q2 amidst the challenging season, highlighting the success of insecticides and biostimulants over herbicides.
• El Niño-driven insecticide surge offsets herbicide weakness: Q2 outperformance is specifically attributed to an insecticide-led portfolio (LaNevo, Miyako, Mortar) capitalizing on El Niño pest dynamics, while the herbicide segment was heavily compressed by the dry spell, representing a significant temporary mix shift.
• Proactive inventory management mitigates RM cost volatility: Management distinguishes Dhanuka from industry peers by highlighting conservative procurement and lean channel inventory as a deliberate strategy to avoid high-cost inventory traps in a volatile raw material pricing environment.
• High commodity prices maintain farmer cash flow: Management notes that high chilli, cotton, and sugar prices provide underlying farmer liquidity, enabling input spending in regions with available water, partially offsetting volume stress from the drought.

Operational commentary

• Product mix for Q2FY27 stood at: Insecticides 47%, Fungicides 25%, Herbicides 8%, Others 20%; North region contributed 31%, South 29%, West 28%, and East 12%.
• Insecticides saw strong growth led by LaNevo, Miyako, Decide, and Mortar, particularly in southern chilli belts and cotton crops.
• Herbicides dropped to 8% share due to a 13% deficit in monsoon rainfall affecting Kharif sowing in rain-dependent regions like Maharashtra, Gujarat, and Madhya Pradesh.
• Dahej capacity expansion underway; the plant will add 2 new fungicide molecules in FY28, expanding the product portfolio from 2 to 4 products targeting the domestic Indian market.
• International export business established subsidiaries in Europe and Brazil strictly for holding registrations; appointed customers in 14 countries with purchase orders in hand from 5 countries.
• Regulatory vigilance and government E-Token enforcement have significantly reduced aggressive bundling/tagging of crop protection chemicals by fertilizer companies.

Analyst Q&A

• Q. What is the specific revenue contribution and run-rate of the newly launched insecticide LaNevo?

  Declined to disclose product-specific revenue numbers on the call.

• Q. What is the expected capex amount for the planned Dahej synthesis plant expansion?

  Deferred disclosing specific capex figures, stating clarity would be provided in the next round.

• Q. What drove gross margin resilience despite lower contribution from high-margin herbicide/fungicide and ITI categories?

  Management attributed it to tight control on other expenses for EBITDA margins, price hikes where possible, and dynamic procurement since July 2026, while clarifying that reported gross margin had an underlying drag from GST refund adjustments.

View source

Research and educational content only. Not investment advice.